Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New confidence bounds for QT studies.

Dennis D Boos1, David Hoffman, Robert Kringle

  • 1Department of Statistics, North Carolina State University, P.O. Box 8203, Raleigh, NC 27695-8203, USA. boos@stat.ncsu.edu

Statistics in Medicine
|February 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pearling drives mitochondrial DNA nucleoid distribution.

Science (New York, N.Y.)·2026
Same author

Pairwise Comparisons of <math><semantics><mrow><mi>k</mi></mrow> <annotation>$$ k $$</annotation></semantics></math> Binomial Responses.

Statistics in medicine·2026
Same author

Survey of work-from-home experiences among medical physicists in Southern California during and after the COVID-19 pandemic.

Journal of applied clinical medical physics·2026
Same author

Waterfowl Move Less in Heterogeneous and Human-Populated Landscapes, With Implications for Spread of Avian Influenza Viruses.

Ecology letters·2026
Same author

Bilateral Cleft Lip Repair.

Facial plastic surgery clinics of North America·2025
Same author

Nature's first electrical tool: microbial biofilms using electron transfer networks to perform aerobic respiration in an anaerobic environment.

Bioelectrochemistry (Amsterdam, Netherlands)·2025

New statistical bounds improve the assessment of pharmaceutical effects on the QT interval, offering a more precise method for drug safety evaluations. These bounds are more efficient for analyzing electrocardiogram data in clinical trials.

Area of Science:

  • Pharmacology and Toxicology
  • Biostatistics
  • Cardiology

Background:

  • Current guidelines for assessing pharmaceutical effects on the QT interval rely on conservative statistical methods.
  • These methods often use one-sided 95% upper confidence bounds, which can be overly cautious in practice.
  • Accurate assessment of QT interval prolongation is crucial for drug safety and regulatory approval.

Purpose of the Study:

  • To propose novel statistical bounds for evaluating the maximum effect of new pharmaceutical agents on the QT interval.
  • To develop bounds that are less conservative yet maintain correct statistical coverage.
  • To provide improved methods applicable to both crossover and parallel clinical trial designs.

Main Methods:

  • Development of new analytical bounds for the maximum QT interval effect.

Related Experiment Videos

  • Implementation of bootstrap-based methods for estimating QT interval bounds.
  • Evaluation of bound performance in realistic parameter spaces for crossover and parallel designs.

    • Main Results:

    • The proposed analytical and bootstrap bounds are shown to be lower than traditional methods.
    • These new bounds achieve correct coverage probabilities in simulated scenarios.
    • The methods are validated for their applicability in common clinical trial designs.

    Conclusions:

    • The novel statistical bounds offer a more efficient and accurate approach to assessing drug-induced QT interval changes.
    • These improved methods can lead to more refined drug safety assessments in pharmaceutical development.
    • The findings support the adoption of these bounds in regulatory guidelines for new drug evaluations.